About Us
Mission
Members
Board of Directors
Staff
Annual Meeting
Economic Impact
Issues
PAMA
Economic Impact of Clinical Labs
Protecting Access to Medicare Act
Laboratory Developed Tests
Reimbursement and Coverage
Patient Access to Lab Services
Value of Labs
IOAS Exception and Self-Referral
Regulatory Issues
Value of Health IT Data Standards
TRICARE Non-Coverage of LDTs
Take Action
News
ACLA Blog
ACLA Press Releases
Comments and Letters
ACLA In The News
Resources
CPT Committee
NCS NCD Work Group
Prior Authorization Work Group
Join Us
Home
Contact Us
Annual Meeting
Home
Contact Us
Annual Meeting
About Us
Mission
Members
Board of Directors
Staff
Annual Meeting
Economic Impact
Issues
PAMA
Economic Impact of Clinical Labs
Protecting Access to Medicare Act
Laboratory Developed Tests
Reimbursement and Coverage
Patient Access to Lab Services
Value of Labs
IOAS Exception and Self-Referral
Regulatory Issues
Value of Health IT Data Standards
TRICARE Non-Coverage of LDTs
Take Action
News
ACLA Blog
ACLA Press Releases
Comments and Letters
ACLA In The News
Resources
CPT Committee
NCS NCD Work Group
Prior Authorization Work Group
Join Us
ACLA News
Statement from the American Clinical Laboratory Association on the announcement by CMS of Appointees to the Advisory Panel on Clinical Diagnostic Laboratory Tests
August 07, 2015
Categories:
ACLA News
,
News
,
Featured News
,
ACLA Press Releases
Download (PDF, 109KB)
Print page / Save as PDF
